Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.

Passage Bio, Inc. (($PASG)) announced an update on their ongoing clinical study. Study Overview: Passage Bio, Inc. is conducting a Phase 1b ...

Let’s be honest — cancer is the uninvited guest who overstays their welcome, and the older we get, the more likely they are ...

ACADIA Pharmaceuticals Inc. (($ACAD)) announced an update on their ongoing clinical study. ACADIA Pharmaceuticals Inc. is conducting a Phase 3, ...

Dr. Joel Salinas, founder and chief medical officer of Isaac Health, examines the growing dementia crisis as a looming ...

The number of people who initiate fertility treatments every year went up from 6,000 in 1991 to nearly 25,000 in 2018.

In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT columnist Jason Karlawish.

Parkinson’s disease and Lewy Body Dementia (LBD) are brain diseases that affect millions of people in the United States. They ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

Texas voters will decide whether to establish a new state-funded institute dedicated to dementia research and prevention-- DPRIT.

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...

Science minister Sir Patrick Vallance said he was "super excited" by advancements in dementia diagnosis and treatment ...